Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDARUBICIN vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDARUBICIN vs IMATINIB: Safety Overview

Metric IDARUBICIN IMATINIB
Total FAERS Reports 5,038 43,161
Deaths Reported 1,260 13,761
Death Rate 25.0% 31.9%
Hospitalizations 1,856 7,264
Average Patient Age 44.8 yrs 55.7 yrs
% Female Patients 46.2% 47.2%
FDA Approval Date Apr 25, 1995 Apr 14, 2025
Manufacturer Pfizer Laboratories Div Pfizer Inc Dr.Reddy's Laboratories Inc
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued